Sentence examples for state clinical from inspiring English sources
This is the case, as subsequent chapters detail, because for those many "freed" from social security and workplace insurance of the declining welfare state, clinical labor provides a necessary source of subsistence, creating income opportunities for the unemployed and working poor populations in their capacity as experimental or reproductive bodies in a global service economy (p. 81).
We found that OS-associated factors were gender, functional state, clinical stage, serum CEA levels, and EGFR tissue expression.
As DRGs are not available in Kwara State, clinical pathways for CVD prevention care were developed based on international guidelines for CVD prevention care.
As Singer et al state, "clinical ethics is not founded in philosophy, law, or theology but, instead, is a subdiscipline of medicine, centering upon the doctor-patient relationship".
An exploratory analysis of the individual features common across predictive studies shows that age, malignant disease state, clinical assessments of circulatory and respiratory compromise, higher temperatures and bone marrow suppression all have some explanatory power.
The dose-escalation design of the ongoing trial has been chosen to target steady state clinical factor IX expression at not greater than 40% of normal factor IX levels for this phase 1/2 safety study.
In addition, some states have additional laws regulating in-state clinical laboratories or the analysis of their residents' samples, independent of where the analysis is conducted.
An important and relatively successful application of capnography in the nonsteady-state clinical setting has been during CPR [ 1, 3, 25].
The correlation at 3 hours from arrival at ICU (the moment of steady-state clinical condition) showed a better agreement (R = 0.82; P < 0.001) with a bias of 0.02 (95% CI -0.78 to 0.86).
A quantitative systems pharmacology model that combines in vitro/preclinical neurophysiology data, human imaging data, and patient disease information was used to blindly predict steady-state clinical efficacy of vabicaserin, a 5-HT2C full agonist, in monotherapy and, subsequently, to assess adjunctive therapy in schizophrenia.
The purpose of this study was to utilize a quantitative systems pharmacology model to predict steady-state clinical efficacy of vabicaserin as a monotherapy and, subsequently, to estimate the efficacy of vabicaserin as an adjunctive therapy in schizophrenia and to inform whether additional clinical studies with vabicaserin are warranted.
